The U.S. Ophthalmic Devices and Eye Care Market was valued at USD 22.9 billion in 2024, and is projected to reach USD 34.29 billion by 2030, rising at a CAGR of 7.14%. The U.S. market is growing due to the increasing prevalence of eye disorders such as cataracts, glaucoma, diabetic retinopathy, and refractive errors, fueled by the rising geriatric population more susceptible to these conditions. For instance, according to the CDC WONDER, Single-Race Population Estimates, 2023, around 17.7% of the country’s population was aged 65 years and above in 2023. In addition, growing awareness of eye health and strategic industry initiatives, such as innovative product launches and collaborations, contribute to market expansion.
A primary driver for the market’s growth is the rapidly aging population. Individuals aged 65 and older are disproportionately affected by age-related eye conditions such as cataracts, age-related macular degeneration (AMD), glaucoma, and presbyopia, necessitating increased demand for diagnostic services, surgical interventions, and vision correction. According to the data published by the CDC in October 2024, in 2022, an estimated 4.22 million US adults (1.62%) had glaucoma, and 1.49 million (0.57%) had vision-affecting glaucoma. Similarly, the rising prevalence of systemic diseases such as diabetes contributes significantly to the burden of eye disease, particularly diabetic retinopathy, further boosting the need for specialized eye care and related devices. According to the International Diabetes Federation, the prevalence of diabetes in the U.S. is estimated to be around 13.7% in 2024, with approximately 38.5 million people living with the disease.
This product will be delivered within 2 business days.
A primary driver for the market’s growth is the rapidly aging population. Individuals aged 65 and older are disproportionately affected by age-related eye conditions such as cataracts, age-related macular degeneration (AMD), glaucoma, and presbyopia, necessitating increased demand for diagnostic services, surgical interventions, and vision correction. According to the data published by the CDC in October 2024, in 2022, an estimated 4.22 million US adults (1.62%) had glaucoma, and 1.49 million (0.57%) had vision-affecting glaucoma. Similarly, the rising prevalence of systemic diseases such as diabetes contributes significantly to the burden of eye disease, particularly diabetic retinopathy, further boosting the need for specialized eye care and related devices. According to the International Diabetes Federation, the prevalence of diabetes in the U.S. is estimated to be around 13.7% in 2024, with approximately 38.5 million people living with the disease.
U.S. Ophthalmic Devices And Eye Care Market Report Segmentation
This report forecasts revenue growth at a country level and analyzes the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the U.S. ophthalmic devices and eye care market report based on product, application, and end-use:Product Outlook (Revenue, USD Million, 2018-2030)
- Ophthalmic Devices
- Optical Coherence Tomography Scanners
- Fundus Cameras
- Perimeters/Visual Field Analyzers
- Autorefractors and Keratometers
- Ophthalmic Ultrasound Imaging Systems
- Tonometers
- Slit Lamps
- Phoropters
- Wavefront Aberrometers
- Optical Biometry Systems
- Ophthalmoscopes
- Lensmeters
- Corneal Topography Systems
- Specular Microscopes
- Retinoscopes
- Eye Care
- Contact Lenses
- Intraocular Lenses
- Ocular Health Products
- Others
Application Outlook (Revenue, USD Million, 2018-2030)
- Cataract
- Vitreo retinal disorders
- Glaucoma
- Refractive Disorders
End-use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals and Eye Clinics
- Academic and Research Laboratory
- Others
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. Ophthalmic Devices and Eye Care Market Variables, Trends & Scope
Chapter 4. U.S. Ophthalmic Devices and Eye Care Market: Product Estimates & Trend Analysis
Chapter 5. U.S. Ophthalmic Devices and Eye Care Market: Application Estimates & Trend Analysis
Chapter 6. U.S. Ophthalmic Devices and Eye Care Market: End Use Estimates & Trend Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The major companies featured in this U.S. Ophthalmic Devices and Eye Care market report include:- Nidek Co. Ltd.
- Johnson & Johnson Vision Care
- Sevenoe
- Duckworth& Kent
- Alcon
- Carl Zeiss Meditec AG
- Topcon Corporation
- NIDEK Co., Ltd.
- Glaukos Corporation
- CooperVision, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 125 |
| Published | May 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 22.9 Billion |
| Forecasted Market Value ( USD | $ 34.29 Billion |
| Compound Annual Growth Rate | 7.1% |
| Regions Covered | United States |
| No. of Companies Mentioned | 11 |
